| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/02/1993 | US5190923 Peptide compounds containing a cyclic amide structure |
| 03/02/1993 | US5190922 Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands |
| 03/02/1993 | US5190921 Amino acids and peptides having a modified tyrosine residue, their preparation and their application as medicaments |
| 03/02/1993 | US5190862 Peptide modified compound |
| 02/28/1993 | CA2075868A1 Method of separating organic solvents |
| 02/27/1993 | WO1993004080A1 Pseudopentapeptides with immunomodulating activity |
| 02/27/1993 | CA2094822A1 Pseudopentapeptides with immunomodulating activity |
| 02/25/1993 | DE4127790A1 New oligopeptide(s) and metal complexes - used in skin-care cosmetics |
| 02/24/1993 | EP0528633A1 Pyrimidinyl acetamides as elastase inhibitors |
| 02/24/1993 | EP0528629A2 Enzymatic synthesis of renin inhibitors |
| 02/24/1993 | EP0528487A2 Novel chromophore containing compounds |
| 02/24/1993 | EP0528486A2 Non-substrate inhibitors of farnesyl protein transferase |
| 02/24/1993 | EP0528242A2 Trifluoromethyl containing pseudopeptides |
| 02/24/1993 | EP0527889A1 Quinolizinone type compounds |
| 02/24/1993 | EP0527764A1 Phosphonopeptides with collagenase inhibiting activity |
| 02/24/1993 | EP0527761A1 Phosphonopeptides with collagenase inhibiting activity |
| 02/24/1993 | CA2076619A1 2-piperazinone compounds, their production and use |
| 02/23/1993 | US5189178 Preventing protein destruction |
| 02/23/1993 | US5189061 Fungicide |
| 02/23/1993 | US5189050 Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder |
| 02/23/1993 | US5189023 Hypotensive agent |
| 02/23/1993 | US5189016 Nutrient compositions containing peptides and method for administering the same |
| 02/18/1993 | WO1993003055A1 Peptide compounds inhibiting hiv adsorption on target cells |
| 02/18/1993 | WO1993003054A1 Novel tetrapeptide derivative |
| 02/18/1993 | WO1993002689A1 Synthetic ribonucleases and methods for preparing and using same |
| 02/18/1993 | WO1993002667A1 Pharmaceutical composition |
| 02/18/1993 | WO1992014696A3 SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES |
| 02/17/1993 | EP0527189A1 Novel cc-1065 analogs |
| 02/17/1993 | CA2075685A1 Chromophore containing compounds and their use in determining interleukin-1b convertase activity |
| 02/17/1993 | CA2075682A1 Affinity chromatography matrix useful in purifying interleukin-1b converting enzyme |
| 02/17/1993 | CA2075678A1 Non-substrate inhibitors of farnesyl protein transferase |
| 02/17/1993 | CA2075662A1 Chromophore containing compounds and their use in determining interleukin-1b convertase activity |
| 02/16/1993 | US5187264 Technetium chelates to be used for determining the renal function |
| 02/16/1993 | US5187195 Anthraquinone derivatives and preparation thereof |
| 02/16/1993 | US5187157 Peptide boronic acid inhibitors of trypsin-like proteases |
| 02/16/1993 | US5187156 Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
| 02/16/1993 | CA1313724C Aminoacid derivatives as antihypertensives |
| 02/13/1993 | CA2075771A1 Enzymatic synthesis of renin inhibitors |
| 02/13/1993 | CA2075748A1 Enzymatic deprotection of peptides |
| 02/11/1993 | CA2075547A1 Trifluoromethyl-containing pseudopeptides |
| 02/10/1993 | EP0527069A1 Derivatives of pyrrolidine and thiazolidine, their preparation, and pharmaceutical compositions containing them |
| 02/10/1993 | EP0526877A2 Peptide aldehydes as antithrombotic agents |
| 02/10/1993 | EP0526854A2 Method for recovery of alpha-L-aspartyl-L-phenylalanine methyl ester, L-phenylalanine and l-aspartic acid |
| 02/09/1993 | US5185464 Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor |
| 02/09/1993 | US5185324 Enzyme-inhibiting amino acid derivatives, a process for the preparation thereof, agents containing these, and the use thereof |
| 02/07/1993 | CA2075154A1 Peptide aldehydes as antithrombotic agents |
| 02/04/1993 | WO1993002099A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 02/04/1993 | WO1993001828A1 Lipid conjugates of therapeutic peptides and protease inhibitors |
| 02/04/1993 | CA2113358A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 02/04/1993 | CA2113156A1 Lipid conjugates of therapeutic peptides and protease inhibitors |
| 02/03/1993 | WO1993003013A1 Indoline derivatives having an amide function, their preparation, and pharmaceutical compositions containing them |
| 02/03/1993 | EP0526348A1 Indoline derivatives carrying an amide function, their preparation and pharmaceutical compositions containing them |
| 02/03/1993 | EP0526192A2 Hexapeptide |
| 02/03/1993 | EP0526009A1 Inhibitors of hiv protease useful for the treatment of aids |
| 02/03/1993 | EP0525420A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors |
| 02/02/1993 | CA1313371C Fused azepinone and azocinone derivatives, processes for their preparation, agents containing them and their use, and intermediates in their preparation |
| 01/31/1993 | CA2074967A1 Hexapeptide |
| 01/27/1993 | EP0524553A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 01/27/1993 | EP0524208A1 Procedure for determining plasmin activity |
| 01/27/1993 | CN1068333A Pharmacologically active hydrazine derivatives and processes for preparation thereof |
| 01/26/1993 | US5182266 Method for treating renal disease |
| 01/26/1993 | US5182265 Pharmacologically active peptide derivatives and pharmaceutical preparations containing them |
| 01/21/1993 | WO1993001208A1 2-[3-(4-amidinophenyl)]propionic acid derivatives, their preparation and their use |
| 01/21/1993 | WO1993001206A1 Conformationally restricted biologically active peptides, methods for their production and uses thereof |
| 01/21/1993 | WO1993001169A2 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/21/1993 | WO1993001167A1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same |
| 01/21/1993 | WO1993001165A2 Aromatic compounds, compositions containing them and their use in therapy |
| 01/21/1993 | WO1993001160A1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/21/1993 | WO1993001159A1 Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/21/1993 | WO1993000926A1 Treatment of periodontal disease with protease inhibitors |
| 01/21/1993 | WO1992022523A3 Peptide derivatives of collagenase inhibitor |
| 01/21/1993 | CA2112580A1 2-substituted 3-(4-amidinophenyl) propionic acid derivatives, the preparation and use thereof |
| 01/21/1993 | CA2110725A1 Aromatic compounds, compositions containing them and their use in therapy |
| 01/21/1993 | CA2110514A1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/21/1993 | CA2110513A1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/20/1993 | WO1993002101A1 Method for crystallizing alpha-l-aspartyl-l-phenylalanine methyl ester |
| 01/20/1993 | WO1993002100A1 Method for crystallizing alpha-l-aspartyl-l-phenylalanine methyl ester |
| 01/20/1993 | EP0523873A1 Non-substrate peptide inhibitors of farnesyl protein transferase |
| 01/20/1993 | EP0523813A1 Method for crystallizing alpha-L-aspartyl-L-phenylalanine methyl ester |
| 01/20/1993 | EP0523461A2 Process for the saponification of aminoacid-/peptide ester |
| 01/20/1993 | EP0523449A2 Reductive amination of an aminoacid or an aminoacid derivative with an alpha-keto acid or an alpha-keto acid derivative |
| 01/20/1993 | CA2089359A1 Method for crystallizing alpha-l-aspartyl-l-phenylalanine methyl ester |
| 01/20/1993 | CA2089358A1 Method for crystallizing alpha-l-aspartyl-l-phenylalanine methyl ester |
| 01/19/1993 | US5180816 Fab fragments, sulfhydryl containing coupler, thioester |
| 01/19/1993 | US5180712 Alzheimer's disease |
| 01/19/1993 | CA1312995C Method for producing indan derivatives |
| 01/16/1993 | CA2073818A1 Transesterification and other conversion reactions of acid derivatives, using an amidine |
| 01/13/1993 | EP0522808A2 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/13/1993 | EP0522482A2 Coccidiosis vaccines |
| 01/13/1993 | EP0522081A1 Inhibition of disease associated with immunodeficiency virus infection |
| 01/13/1993 | CA2073588A1 Coccidiosis vaccines |
| 01/12/1993 | US5179009 Biosynthesis, artificial sweeteners |
| 01/12/1993 | US5178877 Cardiovascular disorders |
| 01/12/1993 | CA1312703C Derivatives of the n-arylsulphonylaminoacyl-p- amidinophenylalaninamides, their preparation process, their use as medicaments and the pharmaceutical compositions containing them |
| 01/12/1993 | CA1312702C Oligopeptidyl nitrile derivatives, agents containing them, a process for their preparation, and their use |
| 01/11/1993 | CA2073499A1 Inhibitors of hiv protease useful for the treatment of aids |
| 01/09/1993 | CA2046484A1 Peptides |
| 01/07/1993 | WO1993000362A1 New peptides (didemnins), their preparation and their use |
| 01/07/1993 | WO1993000359A1 Modified peptides transportable into the central nervous system |
| 01/07/1993 | WO1993000108A1 Novel inhibitors of platelet aggregation |